QNT
QNTCIK 0002110105
Large by assets
Assets $3.2B
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
8-K
Filed Sep 8, 2026
· Period ending Sep 8, 2026
Summary not yet generated.
10-Q
Filed Aug 13, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
Partner
Trade QNT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Aug 11, 2026
· Period ending Aug 11, 2026
Summary not yet generated.
S-1/A
Filed Jun 1, 2026
Red flag
Quantinuum files for IPO, offering 26.5M shares at $54.00 each, raising $1.4B for the company
8 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Aug 13, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(Dollars in thousands except share data)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenue—net | 7,998 | 2,108 | 13,235 | 21,193 |
| Costs and expenses: | ||||
| Cost of revenue | 10,312 | 1,205 | 11,424 | 2,670 |
| Amortization expense | 4,185 | 2,839 | 8,370 | 5,678 |
| Research and development expenses—net | 367,292 | 39,667 | 421,951 | 75,440 |
| Sales and marketing expenses | 29,328 | 3,413 | 43,064 | 6,802 |
| General and administrative expenses | 151,907 | 6,071 | 160,603 | 11,569 |
| Total costs and expenses | 563,024 | 53,195 | 645,412 | 102,159 |
| Loss from operations | (555,026) | (51,087) | (632,177) | (80,966) |
| Interest income—net | (4,719) | (999) | (9,483) | (2,343) |
| Loss on change in fair value of warrant liabilities | 47,615 | 6,400 | 111,815 | 7,800 |
| Other (income)/expense—net | (1,971) | 429 | (2,013) | 800 |
| Loss before taxes | (595,951) | (56,917) | (732,496) | (87,223) |
| Tax expense | 569 | — | 617 | 183 |
| Net loss | (596,520) | (56,917) | (733,113) | (87,406) |
| Less: Net loss attributable to Quantinuum (Cayman) prior to the Transactions | (110,087) | N/A | (246,680) | N/A |
| Less: Net loss attributable to the non-controlling interest | (421,015) | N/A | (421,015) | N/A |
| Net loss attributable to Quantinuum Inc. | (65,418) | N/A | (65,418) | N/A |
| Net loss per share attributable to Class A common stockholders—basic and diluted(1) | (1.93) | N/A | (1.93) | N/A |
| Weighted-average shares used in computing net loss per share attributable to Class A common stockholders—basic and diluted(1) | 33,914,995 | N/A | 33,914,995 | N/A |
Condensed Consolidated Balance Sheets (Unaudited)
(Dollars in thousands except share data)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | 2,106,686 | 762,642 |
| Accounts receivable | 3,348 | 5,068 |
| Due from related parties | 532 | 604 |
| Net investment in lease, current | 5,773 | 5,773 |
| Other current assets | 32,357 | 27,754 |
| Total current assets | 2,148,696 | 801,841 |
| Property and equipment—net | 150,611 | 120,965 |
| Right-of-use assets | 30,911 | 10,000 |
| Goodwill | 769,631 | 784,822 |
| Other intangible assets—net | 105,105 | 114,282 |
| Net investment in lease, non-current | 7,216 | 10,102 |
| Prepayment to related parties, non-current | 14,136 | — |
| Other assets—net | 3,665 | 3,613 |
| Total assets | 3,229,971 | 1,845,625 |
| LIABILITIES | ||
| Current liabilities: | ||
| Accounts payable | 29,393 | 10,620 |
| Due to related parties | 52 | 1,273 |
| Accrued liabilities | 109,286 | 44,358 |
| Total current liabilities | 138,731 | 56,251 |
| Warrant liability | — | 38,400 |
| License payable, non-current portion | 55,345 | 55,345 |
| Operating lease liabilities, non-current | 29,860 | 7,143 |
| Other liabilities | 681 | 893 |
| TEMPORARY EQUITY | ||
| Series A convertible redeemable preferred stock, $0.0001 par value per share; 31,983,034 shares authorized as of December 31, 2025; 23,119,001 shares issued and outstanding as of December 31, 2025; liquidation preference of $423,540 as of December 31, 2025 | — | 288,129 |
| Series A-1 convertible redeemable preferred stock, $0.0001 par value per share; 28,016,966 shares authorized, issued and outstanding as of December 31, 2025; liquidation preference of $479,930,628 as of December 31, 2025 | — | 400,978 |
| Series B convertible redeemable preferred stock, $0.0001 par value per share; 31,753,266 shares authorized as of December 31, 2025; 31,336,698 shares issued and outstanding as of December 31, 2025; liquidation preference $878,367,645 as of December 31, 2025 | — | 824,834 |
| SHAREHOLDERS' EQUITY / QUANTINUUM (CAYMAN) EQUITY | ||
| Quantinuum (Cayman) equity | — | 173,652 |
| Preferred stock, $0.0001 par value per share; 20,000,000 shares authorized, as of June 30, 2026; no shares issued and outstanding as of June 30, 2026 | — | — |
| Class A common stock, $0.0001 par value per share; 2,000,000,000 shares authorized as of June 30, 2026; 36,134,196 shares issued and outstanding as of June 30, 2026 | 3 | — |
| Class B common stock, $0.0001 par value per share; 2,000,000,000 shares authorized as of June 30, 2026; 226,771,877 shares issued and outstanding as of June 30, 2026 | 23 | — |
| Additional paid-in-capital | 480,105 | — |
| Accumulated other comprehensive (loss) income | (1,631) | — |
| Accumulated deficit | (65,418) | — |
| Total equity attributable to Quantinuum Inc. / Quantinuum (Cayman) | 413,082 | 173,652 |
| Non-controlling interest | 2,592,272 | — |
| Total equity | 3,005,354 | 173,652 |
| Total liabilities and equity | 3,229,971 | 1,845,625 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(Dollars in thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (733,113) | (87,406) |
| Adjustments to reconcile to net cash used for operating activities | ||
| Depreciation and amortization | 18,460 | 14,851 |
| Noncash lease expense | 230 | 1,395 |
| Sales under sales-type lease | — | (16,526) |
| Stock compensation expense | 447,454 | — |
| Loss on change in fair value of warrant liabilities | 111,815 | 7,800 |
| (Gain)/Loss on disposal and write down of assets | (10) | 901 |
| Interest expense | 4 | 4 |
| Foreign exchange (gain)/loss—net | 62 | (15) |
| Access to quantum computing hardware | 4,648 | 2,991 |
| Changes in operating assets and liabilities | ||
| Accounts receivable | 1,690 | 1,843 |
| Due from related parties | 38 | 229 |
| Other current assets | (11,082) | 565 |
| Net investment in leases | 2,886 | 2,886 |
| Prepayment to related parties, non-current | (14,136) | — |
| Other assets—net | 472 | 1,516 |
| Accounts payable | 15,463 | 4,387 |
| Due to related parties | (710) | (534) |
| Accrued liabilities | 26,943 | (746) |
| Other liabilities | (199) | 79 |
| Net cash used for operating activities | (129,085) | (65,780) |
| Cash flows from investing activities: | ||
| Capital expenditures | (39,177) | (37,721) |
| Net cash used for investing activities | (39,177) | (37,721) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock | 1,628,774 | — |
| Common stock issuance costs | (23,534) | — |
| Withholding taxes paid on stock compensation | (91,984) | — |
| Net cash provided by financing activities | 1,513,256 | — |
| Effect of exchange rate changes on cash and cash equivalents | (950) | 23 |
| Net increase (decrease) in cash and cash equivalents | 1,344,044 | (103,478) |
| Cash and cash equivalents at beginning of period | 762,642 | 172,343 |
| Cash and cash equivalents at end of period | 2,106,686 | 68,865 |
| Non-cash investing and financing activities: | ||
| Unpaid purchases of property and equipment | 9,227 | 8,348 |
| Unpaid withholding taxes on stock compensation | 38,692 | — |
| Unpaid issuance costs | 5,672 | — |
| Value of shares issued via cashless warrant exercise | 150,215 | — |
Amounts as printed on the EDGAR/iXBRL face — (Dollars in thousands except share data); (Dollars in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗